EUVIMEDEUVIMED entdecken
Crossref

The utility of p63, CK7 , and CAM5 .2 staining in differentiating pagetoid intraepidermal carcinomas

Rebekah Wieland iD, Prajesh Adhikari, Jeffrey North iD

Journal of Cutaneous Pathology · 2023

DOI: 10.1111/cup.14446 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cutaneous Pathology, 2023. Verfasst von Rebekah Wieland und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Stanford University School of Medicine, Stanford, California, USA. Hauptthemen laut MEDLINE: Skin Neoplasms, Carcinoma, Squamous Cell, Paget Disease, Extramammary. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 9 Literaturangaben. Gefördert von: American Society of Dermatopathology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Extramammary Paget disease (EMPD), pagetoid squamous cell carcinoma in situ (PSCCIS), and Paget disease of the breast (PD) are intraepidermal carcinomas with overlapping histopathologic features. CK7 and CAM5.2 stains are frequently utilized to distinguish PSCCIS from EMPD and PD. However, some cases of PSCCIS can stain positively for CAM5.2 and CK7, indicating a potential pitfall with these stains. p63 has been shown to distinguish PSCCIS from EMPD. We assessed p63 staining in PD and compared it to p63 staining of PSCCIS and EMPD.

Methods

A retrospective search for 15 examples each of PSCCIS, EMPD, and PD with remaining tissue in the paraffin block was performed. The diagnosis was confirmed by a board‐certified dermatopathologist and immunostaining for p63, CK7, and CAM5.2 was performed. Staining >55% was scored as positive. Staining

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Skin NeoplasmsCarcinoma, Squamous CellPaget Disease, ExtramammaryHumansRetrospective StudiesStaining and LabelingBiomarkers, TumorKeratinsBiomarkers

Stichwörter der Autor:innen

Paget diseaseextramammaryp63pagetoid intraepidermal carcinomasquamous cell carcinoma in situ

Substanzen

Biomarkers, TumorCAM 5.2 antigenKeratinsBiomarkers

Autor:innen und Institutionen

  • Department of Pathology, Stanford University School of Medicine, Stanford, California, USA.
  • Department of Pathology, Creighton University School of Medicine, Phoenix, Arizona, USA.
  • Departments of Pathology and Dermatology, University of California San Francisco, San Francisco, California, USA.

ORCID-Profile: Rebekah Wieland, Jeffrey North

Förderung

  • American Society of Dermatopathology

Zitieren

APA

Wieland, R., Adhikari, P., & North, J. (2023). The utility of p63, CK7 , and CAM5 .2 staining in differentiating pagetoid intraepidermal carcinomas. Journal of Cutaneous Pathology. https://doi.org/10.1111/cup.14446

Vancouver

Wieland R, Adhikari P, North J. The utility of p63, CK7 , and CAM5 .2 staining in differentiating pagetoid intraepidermal carcinomas. Journal of Cutaneous Pathology. 2023. doi:10.1111/cup.14446

BibTeX
@article{Wieland2023,
  author = {Wieland, Rebekah and Adhikari, Prajesh and North, Jeffrey},
  title = {The utility of p63, CK7 , and CAM5 .2 staining in differentiating pagetoid intraepidermal carcinomas},
  journal = {Journal of Cutaneous Pathology},
  year = {2023},
  doi = {10.1111/cup.14446}
}
Kostenlos starten →